Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.

Suppr

超能文献

作者信息

Parrott A C, Buchanan T, Heffernan T M, Scholey A, Ling J, Rodgers J

出版信息

Psychopharmacology (Berl). 2003 Jun;167(4):449-50. doi: 10.1007/s00213-003-1447-5. Epub 2003 Apr 8.

DOI:10.1007/s00213-003-1447-5

PMID:12682712

Abstract

摘要

相似文献

Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.

Psychopharmacology (Berl). 2003 Jun;167(4):449-50. doi: 10.1007/s00213-003-1447-5. Epub 2003 Apr 8.

Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.

Psychopharmacology (Berl). 2004 Jan;171(2):229-30. doi: 10.1007/s00213-003-1599-3. Epub 2003 Nov 21.

The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).

Psychopharmacology (Berl). 2004 Jan;171(2):231-3. doi: 10.1007/s00213-003-1600-1. Epub 2003 Nov 21.

Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.

Hum Psychopharmacol. 2003 Mar;18(2):89-90. doi: 10.1002/hup.449.

Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.

Drug Alcohol Rev. 2005 Jul;24(4):359-68. doi: 10.1080/09595230500295725.

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.

Eur J Pharmacol. 2004 Oct 1;500(1-3):3-13. doi: 10.1016/j.ejphar.2004.07.006.

What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?

Mov Disord. 2003 Nov;18(11):1219-23. doi: 10.1002/mds.10643.

More about parkinsonism after taking ecstasy.

N Engl J Med. 1999 Oct 28;341(18):1400; author reply 1401.

Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.

Hum Psychopharmacol. 2013 Jul;28(4):289-307. doi: 10.1002/hup.2318.

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.

Psychopharmacology (Berl). 2004 May;173(3-4):398-404. doi: 10.1007/s00213-003-1719-0. Epub 2004 Jan 14.

引用本文的文献

MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.

Psychopharmacology (Berl). 2014 Oct;231(20):4007-18. doi: 10.1007/s00213-014-3536-z. Epub 2014 Apr 1.

Editorial note: MDMA-induced dopamine neurotoxicity.

Psychopharmacology (Berl). 2004 Jan;171(2):228. doi: 10.1007/s00213-003-1678-5. Epub 2003 Nov 21.

本文引用的文献

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.

Addict Behav. 2004 Jun;29(4):743-52. doi: 10.1016/j.addbeh.2004.02.022.

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

Hum Psychopharmacol. 2002 Aug;17(6):309-12. doi: 10.1002/hup.415.

RETRACTED: Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").

Science. 2002 Sep 27;297(5590):2260-3. doi: 10.1126/science.1074501.

The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

CMAJ. 2001 Oct 2;165(7):917-28.

Cognitive performance amongst recreational users of "ecstasy".

Psychopharmacology (Berl). 2000 Jul;151(1):19-24. doi: 10.1007/s002130000467.

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Psychopharmacology (Berl). 1998 Oct;139(3):261-8. doi: 10.1007/s002130050714.

Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Drug Saf. 1996 Aug;15(2):107-15. doi: 10.2165/00002018-199615020-00003.

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Science. 1983 Feb 25;219(4587):979-80. doi: 10.1126/science.6823561.

Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease.

Can J Neurol Sci. 1984 Feb;11(1 Suppl):160-5. doi: 10.1017/s0317167100046333.

Parkinson's disease. Clues to aetiology from a toxin.

Nature. 1984;311(5986):514. doi: 10.1038/311514a0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验